BioCentury | Apr 29, 2013
Company News

Antitope, Research Corporation Technologies Inc. deal

...to disclose details. Antitope could not be reached for details. Antitope Ltd. , Babraham, U.K. Research Corporation Technologies...
BioCentury | Apr 15, 2013
Company News

Oryza Laboratories, Research Corporation Technologies deal

...The reagents are applicable to combinatorial chemistry and solution syntheses. Oryza Laboratories , Chelmsford, Mass. Research Corporation Technologies...
BioCentury | Jul 23, 2012
Company News

Isogenica, Research Corporation Technologies Inc. deal

...engineered for enhanced stability, epitope binding and other properties. Isogenica Ltd. , Little Chesterford, U.K. Research Corporation Technologies...
BioCentury | Mar 29, 2006
Company News

Aegera names Berendt CEO

...Quebec) hired Michael Berendt as president and CEO. Previously, Berendt was a managing director for Research Corporation Technologies...
BioCentury | May 27, 2005
Financial News

Research Corp. names Kirkpatrick CEO

...Technology investment and management company Research Corporation Technologies promoted Shaun Kirkpatrick to CEO from COO while remaining president...
BioCentury | May 26, 2005
Financial News

Cylene raises $26.3 million

...Morningside Venture; TDL Investors; William Harris Investors; Lakeview; and Viterbi Group joined Sanderling; Novartis BioVentures; Research Corporation Technologies...
BioCentury | Oct 4, 2004
Company News

Aradigm, Novo Nordisk deal

...as asthma and chronic obstructive pulmonary disease (COPD) with APT Pharmaceuticals LLC, a division of Research Corporation Technologies...
BioCentury | Sep 29, 2004
Company News

Aradigm, Novo Nordisk expand diabetes deal

...such as asthma and chronic obstructive pulmonary disease (COPD) with APT Pharmaceuticals, a division of Research Corporation Technologies...
BioCentury | Apr 7, 2003
Clinical News

Research Corporation Technologies preclinical data

...Clinic (Rochester, Minn.), is seeking a partner to continue development in CHF and other indications. Research Corporation Technologies...
BioCentury | Mar 6, 2000
Finance

Best of both worlds

...buyout opportunities in the sector (see Ebb & Flow, Nov. 1, 1999). Technology management company Research Corporation Technologies...
Items per page:
1 - 10 of 26
BioCentury | Apr 29, 2013
Company News

Antitope, Research Corporation Technologies Inc. deal

...to disclose details. Antitope could not be reached for details. Antitope Ltd. , Babraham, U.K. Research Corporation Technologies...
BioCentury | Apr 15, 2013
Company News

Oryza Laboratories, Research Corporation Technologies deal

...The reagents are applicable to combinatorial chemistry and solution syntheses. Oryza Laboratories , Chelmsford, Mass. Research Corporation Technologies...
BioCentury | Jul 23, 2012
Company News

Isogenica, Research Corporation Technologies Inc. deal

...engineered for enhanced stability, epitope binding and other properties. Isogenica Ltd. , Little Chesterford, U.K. Research Corporation Technologies...
BioCentury | Mar 29, 2006
Company News

Aegera names Berendt CEO

...Quebec) hired Michael Berendt as president and CEO. Previously, Berendt was a managing director for Research Corporation Technologies...
BioCentury | May 27, 2005
Financial News

Research Corp. names Kirkpatrick CEO

...Technology investment and management company Research Corporation Technologies promoted Shaun Kirkpatrick to CEO from COO while remaining president...
BioCentury | May 26, 2005
Financial News

Cylene raises $26.3 million

...Morningside Venture; TDL Investors; William Harris Investors; Lakeview; and Viterbi Group joined Sanderling; Novartis BioVentures; Research Corporation Technologies...
BioCentury | Oct 4, 2004
Company News

Aradigm, Novo Nordisk deal

...as asthma and chronic obstructive pulmonary disease (COPD) with APT Pharmaceuticals LLC, a division of Research Corporation Technologies...
BioCentury | Sep 29, 2004
Company News

Aradigm, Novo Nordisk expand diabetes deal

...such as asthma and chronic obstructive pulmonary disease (COPD) with APT Pharmaceuticals, a division of Research Corporation Technologies...
BioCentury | Apr 7, 2003
Clinical News

Research Corporation Technologies preclinical data

...Clinic (Rochester, Minn.), is seeking a partner to continue development in CHF and other indications. Research Corporation Technologies...
BioCentury | Mar 6, 2000
Finance

Best of both worlds

...buyout opportunities in the sector (see Ebb & Flow, Nov. 1, 1999). Technology management company Research Corporation Technologies...
Items per page:
1 - 10 of 26